The landscape of the pharmaceutical market place has changed dramatically in recent years; the number of stakeholders and divergence of their agendas have multiplied; cost containment is everywhere; there are new and different growth drivers at play. And the changes are set to continue with accelerating pace.
The sheer complexity which characterises these dynamic and interconnected trends is a major challenge for companies operating in this environment. Many pharmaceutical manufacturers are experiencing difficulty in measuring the market, much less understanding it. To gain insight there is a need for broader, different and deeper information.
Only IMS brings a full continuum of information, analytics and consulting capabilities - as well as 'global-to-local' reach - to help our clients gain a deep understanding of the complex dynamics as they shape new business models and strategies.
The following trends are the most significant in driving industry change:
-
Emerging markets
-
Increased pressure on costs and pricing
-
An ever more generic world
-
The rise of the specialty product
-
The growth of non-retail distribution
-
The informed patient
-
Proving product value
